Taro Pharmaceutical Industries Ltd. total revenue, net income and dynamics of changes in US dollar today
Taro Pharmaceutical Industries Ltd. revenue for the past few reporting periods. Net revenue Taro Pharmaceutical Industries Ltd. is now 147 113 000 $. Information about net revenue is taken from open sources. These are the main financial indicators of Taro Pharmaceutical Industries Ltd.. The financial schedule of Taro Pharmaceutical Industries Ltd. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. Taro Pharmaceutical Industries Ltd. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Information on Taro Pharmaceutical Industries Ltd. net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The latest dates of Taro Pharmaceutical Industries Ltd. financial statements available online: 30/06/2017, 31/03/2021, 30/06/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Taro Pharmaceutical Industries Ltd. is 30/06/2021. Gross profit Taro Pharmaceutical Industries Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Taro Pharmaceutical Industries Ltd. is 77 698 000 $
Cost of revenue Taro Pharmaceutical Industries Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Taro Pharmaceutical Industries Ltd. is 69 415 000 $ Total revenue Taro Pharmaceutical Industries Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Taro Pharmaceutical Industries Ltd. is 147 113 000 $ Operating income Taro Pharmaceutical Industries Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Taro Pharmaceutical Industries Ltd. is 40 770 000 $
Net income Taro Pharmaceutical Industries Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Taro Pharmaceutical Industries Ltd. is -18 767 000 $ Current assets Taro Pharmaceutical Industries Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Taro Pharmaceutical Industries Ltd. is 1 480 767 000 $ Total assets Taro Pharmaceutical Industries Ltd. refers to the total amount of assets owned by a person or entity. Total assets Taro Pharmaceutical Industries Ltd. is 2 413 305 000 $
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
77 698 000 $
76 934 000 $
73 188 000 $
81 588 000 $
94 126 000 $
101 603 000 $
101 724 000 $
119 537 000 $
117 543 000 $
108 562 000 $
100 082 000 $
118 929 000 $
102 916 000 $
125 120 000 $
116 543 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
69 415 000 $
71 414 000 $
66 957 000 $
61 255 000 $
53 557 000 $
59 247 000 $
59 572 000 $
60 384 000 $
58 838 000 $
50 411 000 $
54 536 000 $
56 287 000 $
52 545 000 $
44 795 000 $
44 778 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
147 113 000 $
148 348 000 $
140 145 000 $
142 843 000 $
147 683 000 $
160 850 000 $
161 296 000 $
179 921 000 $
176 381 000 $
158 973 000 $
154 618 000 $
175 216 000 $
155 461 000 $
169 915 000 $
161 321 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
147 683 000 $
160 850 000 $
161 296 000 $
179 921 000 $
176 381 000 $
158 973 000 $
154 618 000 $
175 216 000 $
155 461 000 $
169 915 000 $
161 321 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
40 770 000 $
38 113 000 $
36 309 000 $
40 962 000 $
58 198 000 $
62 412 000 $
68 563 000 $
75 704 000 $
78 934 000 $
74 722 000 $
63 155 000 $
72 962 000 $
63 629 000 $
88 783 000 $
77 636 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-18 767 000 $
-29 786 000 $
32 919 000 $
45 132 000 $
67 682 000 $
56 178 000 $
66 183 000 $
58 434 000 $
93 506 000 $
62 560 000 $
67 277 000 $
86 287 000 $
17 972 000 $
52 393 000 $
54 497 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
12 952 000 $
16 587 000 $
14 081 000 $
16 552 000 $
14 996 000 $
15 539 000 $
13 443 000 $
20 512 000 $
14 726 000 $
14 655 000 $
13 345 000 $
20 308 000 $
17 457 000 $
17 995 000 $
14 658 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
106 343 000 $
110 235 000 $
103 836 000 $
101 881 000 $
89 485 000 $
98 438 000 $
92 733 000 $
104 217 000 $
97 447 000 $
84 251 000 $
91 463 000 $
45 967 000 $
39 287 000 $
36 337 000 $
38 907 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
1 480 767 000 $
1 470 835 000 $
1 522 274 000 $
1 485 830 000 $
1 457 710 000 $
1 479 866 000 $
1 533 655 000 $
1 482 720 000 $
1 461 748 000 $
1 865 004 000 $
1 833 199 000 $
1 896 635 000 $
1 906 923 000 $
1 927 085 000 $
1 934 056 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
2 413 305 000 $
2 406 873 000 $
2 371 824 000 $
2 346 108 000 $
2 290 963 000 $
2 249 706 000 $
2 172 200 000 $
2 135 326 000 $
2 069 518 000 $
2 555 506 000 $
2 477 889 000 $
2 433 210 000 $
2 421 889 000 $
2 413 817 000 $
2 357 647 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
614 888 000 $
605 177 000 $
552 918 000 $
498 796 000 $
509 361 000 $
560 667 000 $
632 986 000 $
567 451 000 $
566 469 000 $
825 600 000 $
641 989 000 $
576 611 000 $
569 193 000 $
503 321 000 $
430 713 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
214 179 000 $
209 501 000 $
189 233 000 $
216 821 000 $
218 639 000 $
203 059 000 $
192 629 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
-
1 422 620 000 $
972 454 000 $
842 765 000 $
638 425 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
222 359 000 $
218 400 000 $
197 355 000 $
224 204 000 $
223 999 000 $
207 717 000 $
197 825 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
9.71 %
9.71 %
9.09 %
10.50 %
10.82 %
8.13 %
7.98 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 658 056 000 $
1 703 649 000 $
1 759 668 000 $
1 727 957 000 $
2 062 934 000 $
2 025 630 000 $
1 969 201 000 $
1 905 536 000 $
1 839 976 000 $
2 342 409 000 $
2 274 672 000 $
2 205 158 000 $
2 198 374 000 $
2 201 042 000 $
2 139 515 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
98 650 000 $
40 754 000 $
82 604 000 $
58 580 000 $
107 479 000 $
75 210 000 $
82 440 000 $
97 894 000 $
87 098 000 $
66 029 000 $
72 668 000 $
Last revenue report of Taro Pharmaceutical Industries Ltd. was 30/06/2021. According to last financial report total revenue in Taro Pharmaceutical Industries Ltd. was 147 113 000 US dollar and changed by -8.793% since last year. Net income in Taro Pharmaceutical Industries Ltd. was -18 767 000 $ in last quartal, net income changes to -128.356%.
Current cash Taro Pharmaceutical Industries Ltd. - the sum of all of the cash a company has on the date of report. Current cash Taro Pharmaceutical Industries Ltd. is 614 888 000 $
